Generics News
-
Cardinal Health closes China distribution business, divests it to Shanghai Pharma
Generics | News | 0 Comment | 02 Feb, 2018
Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding. The sale includes Cardinal Health's pharmaceutica...Read more
-
Telehealth programme by CGH and Philips empowers heart failure patients
Generics | News | 0 Comment | 25 Jan, 2018
Singapore - The positive one-year results of a Heart Failure Telehealth programme, piloted by Changi General Hospital (CGH) and Royal Philips showed a 67 percent reduction in length of hosp...Read more
-
Synthetic virus to tackle antimicrobial resistance
Generics | News | 0 Comment | 24 Jan, 2018
Singapore - NPL, the UK's National Measurement Institute (NMI) and UCL (University College London) have engineered a brand new artificial virus that kill bacteria on first contact, as publi...Read more
-
Single blood test screens for eight cancer types
Generics | News | 0 Comment | 19 Jan, 2018
Singapore - Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer. The ...Read more
-
Genomics reveals key macrophages’ involvement in systemic sclerosis
Generics | News | 0 Comment | 18 Jan, 2018
Singapore - A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease whi...Read more
-
FDA approves Boston Scientific’s spectra wavewriter spinal cord stimulator system
Generics | News | 0 Comment | 16 Jan, 2018
Singapore - Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter Spinal Cord Stimulator (SCS) System. It is the first...Read more
-
Adapsyn Bioscience announces research collaboration with Pfizer Inc.
Generics | News | 0 Comment | 11 Jan, 2018
Adapsyn Bioscience Inc., a biotechnology company focused on the discovery and development of novel medicines derived from evolved small molecule natural products has announced that it has c...Read more
-
Sangamo and Pfizer announce collaboration
Generics | News | 2 Comment | 04 Jan, 2018
Sangamo Therapeutics, Inc. and Pfizer has announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotr...Read more
-
Zomedica Pharmaceuticals enters into license and supply agreement with Celsee
Generics | News | 0 Comment | 26 Dec, 2017
Michigan based veterinary pharmaceutical and diagnostic company, Zomedica Pharmaceuticals has announced that it has entered into a license and supply agreement with Celsee, Inc. Celsee Inc...Read more
-
Array BioPharma collaborates with Pfizer
Generics | News | 0 Comment | 20 Dec, 2017
Array BioPharma has announced that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations,...Read more
-
Sanofi and Regeneron announce positive results for PD-1 antibody
Generics | News | 0 Comment | 14 Dec, 2017
Sanofi and Regeneron has announced positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma. High and durable response rate in disease wi...Read more
-
Sanofi presents R&D strategy and innovative pipeline
Generics | News | 0 Comment | 14 Dec, 2017
Sanofi will host an analyst meeting in Paris today to discuss the company’s Research and Development strategy, development pipeline and milestones for 2018. The company will highlight...Read more
-
Representation disparity in ages below and above 75 years
Generics | News | 0 Comment | 12 Dec, 2017
Singapore - In the first comprehensive analysis of clinical trial enrolment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration (FDA) found signifi...Read more
-
Juno Therapeutics signs three license agreements
Generics | News | 0 Comment | 11 Dec, 2017
US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple myeloma using gamma secretase inhibitors (GSIs) in combination with BC...Read more
-
FDA approves Amgen's Repatha (evolocumab)
Generics | News | 0 Comment | 07 Dec, 2017
Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha (evolocumab) as ...Read more
-
Generics | News | 0 Comment | 01 Dec, 2017
Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the company through the next phase of its evolution. Dr. Cho began hi...Read more
-
Generics | News | 0 Comment | 30 Nov, 2017
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacific Prostate Cancer Patient Coalition with the goal to address the chal...Read more
-
Biohaven receives agreement from FDA on initial pediatric study plan
Generics | News | 0 Comment | 28 Nov, 2017
Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) on the initial pediatric study plan (iPSP...Read more
